newsfilter
← Latest News
ACCESS Newswire·

Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

TAMPA, FL / ACCESSWIRE / May 30, 2023 / Morphogenesis, Inc. , a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor